Coya Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.96

-0.22 (-5.26%)

As of Mar 29, 10:42 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +830.6% upside

Low Target $27.29

Average Target $36.85

High Target $45.13

Current Price $3.96

Current
$3.96

Target
$36.85

$27.29 $36.85 avg $45.13

Scenario Analysis

Bear Case

$27.29

589.1%

Low target

Base Case

$36.85

+830.6%

Avg target

Bull Case

$45.13

+1,039.6%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.75

-48.9% from high

52-Week Low

$3.94

+0.5% from low

Target vs 52W High

$36.85

+375.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%